85 related articles for article (PubMed ID: 26859584)
1. New molecular aspects of endometrial carcinoma.
Nachajova M; Mersakova S; Sivakova J; Krivus S; Szepe P; Hatok J; Adamkov M
Neuro Endocrinol Lett; 2015 Dec; 36(7):638-43. PubMed ID: 26859584
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation in endometrial cancer.
Tao MH; Freudenheim JL
Epigenetics; 2010 Aug; 5(6):491-8. PubMed ID: 20543579
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.
Banno K; Kisu I; Yanokura M; Masuda K; Ueki A; Kobayashi Y; Susumu N; Aoki D
Epigenomics; 2012 Apr; 4(2):147-62. PubMed ID: 22449187
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
[TBL] [Abstract][Full Text] [Related]
6. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
8. Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin CC; Federici MG; Kang L; Boyd J
Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
[TBL] [Abstract][Full Text] [Related]
9. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
10. Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics.
Banno K; Kisu I; Yanokura M; Masuda K; Kobayashi Y; Ueki A; Tsuji K; Yamagami W; Nomura H; Susumu N; Aoki D
Biochem Res Int; 2012; 2012():738274. PubMed ID: 22548175
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
14. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
Zhou XC; Dowdy SC; Podratz KC; Jiang SW
Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.
Nieminen TT; Gylling A; Abdel-Rahman WM; Nuorva K; Aarnio M; Renkonen-Sinisalo L; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Clin Cancer Res; 2009 Sep; 15(18):5772-83. PubMed ID: 19723644
[TBL] [Abstract][Full Text] [Related]
17. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells.
Miyamoto T; Shiozawa T; Kashima H; Feng YZ; Suzuki A; Kurai M; Nikaido T; Konishi I
Endocrinology; 2006 Oct; 147(10):4863-70. PubMed ID: 16825317
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
19. The role of epigenetics in environmental and occupational carcinogenesis.
Ziech D; Franco R; Pappa A; Malamou-Mitsi V; Georgakila S; Georgakilas AG; Panayiotidis MI
Chem Biol Interact; 2010 Nov; 188(2):340-9. PubMed ID: 20599843
[TBL] [Abstract][Full Text] [Related]
20. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
